新闻中心 - Norgen中国区代理商/公司/官网

欢迎来到 Norgen中国区代理商/公司/官网

全国咨询热线： 18372041646

Norgen中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0111替换BioXCell BE0036

invivoCrown IV0106替换BioXCell BE0090

invivoCrown IV0119替换BioXCell BE0004-1

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：15172431432

传真：18372041646

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理CortecNet品牌全系列产品

CortecNet成立于1995年，是一家以稳定同位素为核心驱动的公司，致力于在 NMR、质谱（MS）、磁共振成像（MRI）和PET领域识别、开发和营销创新产品。这些技术在表征蛋白质、生物分子及材料的结构与动力学，以及在代谢成像应用中发挥着关键作用。CortecNet已与国际领先公司和机构建立了牢固的合作关系，开发了利用大肠杆菌、昆虫细胞、哺乳动物细胞和无细胞表达系统进行稳定同位素标记蛋白表达的创新策略。

▍CortecNet产品线

● NMR &Analytica：聚焦于核磁共振技术相关的应用场景，具体产品包括氚代溶剂、D2O回收等一系列与核磁共振分析相关产品和耗材等。

● Nuclear Medicine & lmaging：核医学和成像领域，具体产品有核医学相关业务、超极化MRI以及氚代谢成像等。

● Industry Applications：具体产品涵盖OLED相关，氚代药物、电子领域、体内研究以及能源领域等。

应用领域	目录
NMR &Analytica	Deuterated Solvents;Cell Free Kits;Labeled Amino Acids;All Stable lsotopes;NMR Consumables &Accessories;DNP Radicals;EPR Consumables
Nuclear Medicine & lmaging	Nuclear Medicine;Hyperpolarized-MR;Deuterium Metabolic lmaging
Industry Applications	OLED；Deuterated Drugs；Electronic；In Vivo；Energy

▍CortecNet部分产品列表

品名	货号	规格	CAS号
1,2-Dichlorobenzene-d4	S-2509X-V09B	1 x 5 mL	2199-69-1
1,4-Dichlorobenzene-d4	S-3009X-M05B	1 x 5 g	3855-82-1
Acetic acid-d4	S-0108X-V04A;S-0108X-V11B;S-0105X-V04A	2 x 0.75 mL;1 x 10 mL;2 x 0.75 mL	1186-52-3
Acetone-d6	S-0206X-V06A;S-0206X-V12S;S-0206X-V14B	10 x 0.75 mL;5 x 10 mL Septum Vial;1 x 25 mL	666-52-4
Acetone-d6 with TMS	S-0203B-V06A	10 x 0.75 mL	666-52-4
Acetonitrile-d3	S-0306X-V06A;S-0306X-V11S;S-0306X-V10B	10 x 0.75 mL;1 x 10 mL Septum Vial;1 x 5 mL	2206-26-0
Acetonitrile-d3 with TMS	S-0303B-V04A	2 x 0.75 mL	2206-26-0
Benzene-d6	S-0408X-V06A;S-0408X-V12S;S-0408X-V14B	10 x 0.75 mL;5 x 10 mL Septum Vial;1 x 25 mL	1076-43-3
Benzene-d6 with TMS	S-0408B-V10B	1 x 5 mL	1076-43-3
Chloroform-d	S-0503X-V03A;S-0506X-V03A;S-0506X-V11B	10 x 0.60 mL;10 x 0.6 mL;1 x 10 mL	865-49-6
Chloroform-d with TMS	S-0503B-V03A;S-0503B-V14B;S-0506B-V14B	10 x 0.6 mL;1 x 25 mL;1 x 25 mL	865-49-6
Cyclohexane-d12	S-0608X-V04A;S-0608X-V10B	2 x 0.75 mL;1 x 5 mL	1735-17-7
Deuterium Oxide	W-0403E-V03A;W-0405E-V14B;W-0403E-V14B	10 x 0.60 mL;1 x 25 mL;1 x 25 mL	7789-20-0
Dimethylformamide-d7	S-0708X-V04A;S-0708X-V10B	2 x 0.75 mL;1 x 5 mL	4472-41-7
Dimethylsulfoxide-d6	S-0806X-V06A;S-0806X-V12S;S-0806X-V14B	10 x 0.75 mL;5 x 10 mL Septum Vial;1 x 25 mL	2206-27-1
Dimethylsulfoxide-d6 with TMS	S-0806B-V14B;S-0806B-V12S;S-0803B-V06A	1 x 25 mL;5 x 10 mL;10 x 0.75 mL	2206-27-1
Dioxane-d8	S-0909X-V08A	2 x 1 mL	17647-74-4
DSS	DSSPF	1 g	2039-96-5
Ethanol-d6	S-1009X-V08A;S-1009X-V10B	2 x 1 mL;1 x 5 mL	1516-08-1
Hexafluoroisopropanol-d2	S-1109X-V08A;S-1109X-V10B	2 x 1 mL;1 x 5 mL	38701-74-5
Isopropanol-d8	S-1209X-M06B	1 x 10 g	22739-76-0
Methanol-d1	S-2709X-V14B	1 x 25 mL	1455-13-6
Methanol-d3	S-2806X-V06A;S-2806X-V10B	10 x 0.75 mL;1 x 5 mL	1849-29-2
Methanol-d4	S-1306X-V06A;S-1306X-V12S;S-1306X-V14B	10 x 0.75 mL;5 x 10 mL Septum Vial;1 x 25 mL	811-98-3
Methanol-d4 with TMS	S-1306B-V06B;S-1306B-V11B	10 x 0.75 mL;1 x 10 mL	811-98-3
Methylene Chloride-d2	S-1506X-V06A;S-1506X-V14B;S-1506X-V11B	10 x 0.75 mL;1 x 25 mL;1 x 10 mL	1665-00-5
Pyridine-d5	S-1608X-V06A;S-1608X-V14B;S-1608X-V11B	10 x 0.75 mL;1 x 25 mL;1 x 10 mL	7291-22-7
Sodium Deuteroxide	S-1708X-M08B	1 x 50 g	14014-06-3
Sulfuric Acid-d2	S-2911X-M06B	1 x 10 g	7664-93-9
Tetrachloroethane-d2	S-1807X-V14B;S-1807X-V11B	1 x 25 mL;1 x 10 mL	33685-54-0
Tetrahydrofuran-d8	S-1908X-V04A;S-1908X-V08A;S-1908X-V11B	2 x 0.75 mL;2 x 1 mL;1 x 10 mL	7291-22-7
TMSP-d4	S-2410X-M02B	1 g	24493-21-8
Toluol-d8	S-2007X-V04A;S-2007X-V14B;S-2007X-V11B	2 x 0.75 mL;1 x 25 mL;1 x 10 mL	2037-26-5
Trifluoroacetic Acid-d1	S-2108X-V04A;S-2108X-V11B	2 x 0.75 mL;1 x 10 mL	599-00-8
Trifluoroethanol-d2	S-2210X-V04A	2 x 0.75 mL	77568-66-2
Trifluoroethanol-d3	S-2309X-V04A	2 x 0.75 mL	77253-67-9

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理CortecNet品牌全系列产品"> 艾美捷科技代理CortecNet品牌全系列产品

...

阅读详情

Zedira是一家临床阶段的生物技术公司，专门从事转谷氨酰胺酶的研究，开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域，该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外，Zedira是一个全球品牌，专门用于转谷氨酰胺酶领域的研发和诊断试剂，其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。

Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.

Zedira公司主要产品：

Transglutaminases

Microbial Transglutaminase

Assays and Substrates

Inhibitors

Antibodies and Microarrays

Proteases

Protein Labeling

Blood Coagulation

Cereal Proteins

Celiac Disease Products

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Zedira产品详情请咨询我司客服人员：

产品编号	产品名称	产品规格
A003	Polyclonal antibody to human tissue transglutaminase (TG2)	100 ug
A004	Monoclonal antibody to tissue transglutaminase (TG2)	100 ug
A008	Polyclonal antibody to human transglutaminase 5 (TG5)	500 ug
A011	Monoclonal antibody to gliadin (clone XGY1)	1 mg
A013	Monoclonal antibody to gliadin (clone XGY7)	1 mg
A014	Polyclonal antibody to human tissue transglutaminase (TG2)	500 ug
A015	Polyclonal antibody to human epidermal transglutaminase (TG3)	500 ug
A016	Polyclonal antibody to human blood coagulation factor XIII (A-subunit)	500 ug
A017	Polyclonal antibody to human neuronal transglutaminase (TG6)	500 ug
A018	Polyclonal antibody to human keratinocyte transglutaminase (TGI)	500 ug
A020	Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG)	500 ug
A021	Polyclonal antibody to human plasminogen (rhPLG)	500 ug
A022	Polyclonal antibody to human prostate transglutaminase (TG4)	500 ug
A023	Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond	100 ug
A024	Monoclonal Antibody to microbial (bacterial) Transglutaminase	100 ug
A028	FITC-labeled polyclonal antibody to human TG2	200 ug
A029	FITC-labeled polyclonal antibody to human TGI	200 ug
A030	FITC-labeled polyclonal antibody to human TG3	200 ug
A031	FITC-labeled polyclonal antibody to human TG6	200 ug
A032	FITC-labeled polyclonal antibody to human factor XIII (A-subunit)	200 ug
A033	Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17)	200 ug
A034	Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1)	200 ug
A035	Monoclonal antibodies to gliadin (Set No 1)	1 Set
A036	Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21)	200 ug
A037	Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8)	200 ug
A040	Polyclonal antibody to human transglutaminase 7 (TG7)	200 ug
A042	Monoclonal antibody to human TGI (clone XTG3 1)	200 ug
A044	FITC-labeled polyclonal antibody to human TG5	200 ug
A046	D-Dimer monoclonal mouse antibody, clone 3B6	100 ug
A047	D-Dimer monoclonal mouse antibody, clone 1 D2	100 ug
A051	Biotinylated polyclonal antibody to microbial transglutaminase (MTG)	50 ug
A052	Biotinylated polyclonal antibody to human factor XIII (A-subunit)	50 ug
A053	Biotinylated polyclonal antibody to human TG2	50 ug
A054	Monoclonal antibody to gliadin (clone XGY6)	1 mg
A057	Monoclonal antibody to deamidated gliadin	100 ug
A058	Monoclonal antibody to gliadin (clone XGY5)	1 mg
A059	Monoclonal antibody to gliadin (clone XGY9)	1 mg
A060	Monoclonal antibody to gliadin (clone XGY10)	1 mg
A061	Monoclonal antibody to gliadin (clone XGY 1 6)	1 mg
A062	Monoclonal antibody to deamidated and non-deamidated gliadin	100 ug
A063	Monoclonal antibody to gliadin (clone XGY2)	1 mg
A064	Monoclonal antibody to gliadin (clone XGY4)	1 mg
A065	Monoclonal antibody to gliadin (clone XGY8)	1 mg
A066	Monoclonal antibody to gliadin (clone XGY 1 2)	1 mg
A067	Monoclonal antibody to gliadin (clone XGY 1 5)	1 mg
A068	Monoclonal antibody to gliadin (clone XGY 1 7)	1 mg
A069	Monoclonal antibody to gliadin (clone XGY23)	1 mg
A070	Monoclonal antibody to gliadin (clone XGY24)	1 mg
A071	Monoclonal antibody to hordein (clone XH4)	1 mg
A072	polyclonal antibody to mouse tissue Transglutaminse	200 ug
A074	Polyclonal antibody to human blood coagulation factor XIII (B-subunit)	200 ug
A075	FITC-labeled polyclonal antibody to mouse TG2	200 ug
A076	DD-XLink-mab	100 ug
A077	FITC-labeled polyclonal antibody to human factor XIII (B-subunit)	200 ug
A078	Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A	250 ug
A079	Biotin-DD-XLink-mab	50 ug
A082	Monoclonal antibody to human TG3 (clone XTG45)	200 ug
A101	FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH	10 mg
A102	TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH	10 mg
A105	NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12)	25 mg
A106	(ATTO-48 8TM)cadaveri ne	1 mg
A108	Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH	5 mg
A109	β-Amyloid peptide 1-42 (Aβ 1-42)	1 mg
A112	(ATTO-532)cadaverine	1 mg
A113	(ATTO-550)cadaverine	1 mg
A114	(AnO-647N)cadaverine	1 mg
A115	(ATTO-700)cadaverme	1 mg
A125	Factor XIII activation peptide	10 mg
A132	Ac-WALQRPHYSYPD	10 mg
A139	Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52)	200 ug
A140	Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39)	200 ug
A141	Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68)	200 ug
A142	Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57)	200 ug
A143	Monoclonal antibody to microbial Transglutaminase (clone XM67)	200 ug
A144	Monoclonal antibody to microbial Transglutaminase (clone XM68)	200 ug
A145	Polyclonal Antibody to microbial Transglutaminase	200 ug
A152	3-Azido-l -propanamine	100 mg
A153	4-Azidobutan-l-amine	100 mg
A154	Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09)	200 ug
A155	Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02)	200 ug
B001	Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH	5 mg 25 mg
B002	N-(Biotinyl)cadaverine	25 mg 100 mg
B003	Boc-DON-Gln-lle-Val-OMez "Boc-DON”	10 mg
B006	Thr-Val-Gln-Gln-Glu-Leu-OH	25 mg
B007	Keratinocyte transglutaminase (TGI )-substrate-peptide K5	10 mg
B008	Tissue transglutaminase (TG2)-substrate-peptide T26	10 mg
B009	Epidermal transglutaminase (TG3)-substrate-peptide E51	10 mg
B010	Blood coagulation FXIII-substrate-peptide Fl 1 KA	10 mg
B013	Neuronal transglutaminase (TG6)-substrate peptide Y25	10 mg
B014	Transglutaminase 7 (TG7)-substrate peptide Z3S	10 mg
B015	Biotin-Ahx-MA-QPL-OMe	10 mg
B017	Microbial Transglutaminase (MTG)-substrate peptide M48	10 mg
B019	Biotin-Ahx-QVPL-OMe	10 mg
C001	Z-GIn-Gly-OH	1g
C002	Z-GIn-Gly-CAD-DNS	25 mg 100 mg
C074	Z-Gln-Gly-CAD-(AnO-488)	1 mg
C075	Z-Gln-Gly-CAD-(ATTO-532)	1 mg
C076	Z-Gln-Gly-CAD-(AnO-550)	1 mg
C077	Z-Gln-Gly-CAD-(ATTO-647N)	1 mg
C078	Z-Gln-Gly-CAD-(AnO-700)	1 mg
C079	Z-GIn-Gly-PEG(3)-N3	25 mg
C080	Z-Gln-Gly-PEG(11)-N3	25 mg
C090	Z-GIn-Gly-CAD-TAMRA	25 mg
C091	Z-GIn-Gly-CAD-Biotin	25 mg
C092	Z-Gln-Gly-(PEG1,088), monodisperse	25 mg
C093	Z-Gln-Gly-(PEG5,000), polydisperse	25 mg
C094	Tosyl-ε-aminopentyl-CMK	1 mg
C095	Dansyl-ε-aminopentyl-CMK	1 mg
C102	MTG Blocker	10 mg 25 mg
D001	Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH	25 mg 100 mg
D002	N-(2,4-Dinitrophenyl)cadaverine	100 mg
D003	1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride	100 mg
D004	1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium	10 mg
D005	Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS	2 mg
D006	N-(Dansyl)cadaverine	100 mg
D007	Cadaverine	100 mg
D008	"DALP", DNP-aminohexanoic acid-Lys-aminopropanol	5 mg
D009	DALP-methyl carbamate	5 mg
D0I 6	LDN 27219	10 mg
E018	ZediXclusive Tissue Transglutaminase EIA	1 Kit
E021	ZediXclusive Microbial Transglutaminase (MTG) ELISA	1 Kit
E103	ZediXclusive TG6-ab ELISA (IgA)	1 Kit (96 wells)
E104	ZediXclusive TG6-ab ELISA (IgG)	1 Kit (96 wells)
F001	FXIII-Assay Kit	1 Kit
F002	Tissue Transglutaminase Assay Kit	1 Kit
F004	Fibrinogen, purified from human plasma	50 mg
F006	FITC-labeled Fibrinogen	5 mg
F007	Fibrin Glue (porcine)	1 Kit
F008	Fibrin Glue (bovine)	1 Kit
F011	Cross-linked fibrin degradation products, xFDPs	200 ug
F012	Fibrin degradation products, FDPs	200 ug
G001	Alpha2-gliadin, 33mer (aa56-88), biotinylated	5 mg
G002	Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated	5 mg
G003	Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide	10 mg
G004	Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide	10 mg
G005	DGPx4 (Fusion protein of 4 deamidated gliadin peptides)	500 ug
G006	DGPx2 (Fusion protein of 2 deamidated gliadin peptides)	500 ug
G007	DGPxl (deamidated gliadin peptide)	500 ug
G008	Omega-5 gliadin	500 ug
G009	Alpha2-gliadin, 33mer (aa 56-88)	5 mg
G011	Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E)	5 mg
G013	QPFPQPQLPYPQPQ-amide	10 mg
G014	QPFPQPELPYPQPQ-amide	10 mg
G017	Biotinylated DGPx1	100 ug
G018	Barley albumin and globulin	5 mg
G019	Barley prolamin (Hordein)	5 mg
G020	Barley glutelin (Hordenin)	5 mg
G021	Rye albumin and globulin	5 mg
G022	Rye prolamin (Secalin)	5 mg
G023	Rye glutelin (Secalinin)	5 mg
G024	Corn albumin and globulin	5 mg
G025	Corn prolamin (Zein)	5 mg
G026	Corn glutelin (Zeanin)	5 mg
G027	Rice albumin and globulin	5 mg
G028	Rice prolamin (Oryzin)	5 mg
G029	Rice glutelin (Oryzenin)	5 mg
G030	Spell albumin and globulin	5 mg
G031	Spelt prolamin	5 mg
G032	Spelt glutelin	5 mg
G033	Oat albumin and globulin	5 mg
G034	Oat prolamin (Avenin)	5 mg
G035	Oat glutelin (Avenalin)	5 mg
G036	Wheat albumin and globulin (Leukosin and Edestin)	5 mg
G037	Wheat prolamin (Gliadin)	5 mg
G038	Wheat glutelin (Glutenin)	5 mg
G039	Durum wheat albumin and globulin	5 mg
G040	Durum wheat prolamin	5 mg
G041	Durum wheat glutelin	5 mg
G042	Soy protein, saline soluble fraction	5 mg
G043	Soy protein, ethanol soluble fraction	5 mg
G044	Soy protein, propanol/urea/DTE soluble fraction	5 mg
G045	Millet (Sorghum) albumin and globulin	5 mg
G046	Millet (Sorghum) prolamin (Kafirin)	5 mg
G047	Millet (Sorghum) glutelin	5 mg
G048	L-Glutamic acid γ-monohydroxamate	100 mg
G051	26mer gliadin peptide	250 ug
G052	33mer gliadin peptide	250 ug
G054	33mer DGP	250 ug
G055	Carrier protein control	250 ug
G056	DGP and Gliadin peptides (Set No 1)	1 Set
G057	Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled	5 mg
G058	Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled	5 mg
G101	Gly-Pro-Arg-Pro-amide	25 mg
I001	Involucrme, recombinant human	500 ug
K004	"KxD", Boc-Lys-en-DNS	10 mg
L001	Substrate Finder Kit	1 Kit
L101	Biotin TGase Protein Q-Labeling Kit	1 Kit
L102	PEG1,088 TGase Protein Q-Labeling Kit	1 Kit
L103	PEG5,000 TGase Protein Q-Labeling Kit	1 kit
L104	ATTO-488™ TGase Protein Q-Labeling Kit	1 Kit
L105	ATTO-532™ TGase Protein Q-Labeling Kit	1 Kit
L106	ATTO-550™ TGase Protein Q-Labeling Kit	1 Kit
L107	ATTO-647N™ TGase Protein Q-Labeling Kit	1 Kit
L108	ATTO-700™ TGase Protein Q-Labeling Kit	1 Kit
L201	Biotin TGase Protein K-Labeling Kit	1 Kit
L202	PEG1,088 TGase Protein K-Labeling Kit	1 Kit
L203	PEG5,000 TGase Protein K-Labeling Kit	1 Kit
L204	ATTO-488™ TGase Protein K-Labeling Kit	1 Kit
L205	ATTO-532™ TGase Protein K-Labeling Kit	1 Kit
L206	ATTO-550™ TGase Protein K-Labeling Kit	1 Kit
L207	ATTO-647N™ TGase Protein K-Labeling Kit	1 Kit
L208	ATTO-700™ TGase Protein K-Labeling Kit	1 Kit
M001	MTG-ANiTA-Kit	1 Kit
M003	Tissue Transglutaminase Pico-Assay Kit	1 Kit
P003	Prolylendopeptidase from Myxococcus xanthus, recombinant	150U
P004	PT-Gluten	1 mg 10 mg
P009	human Pro-Glu-Plasminogen, recombinant	100 ug
P010	(PEG1,088)amine, monodisperse	10 mg
P011	(PEG5,000)amine, polydisperse	10 mg
P012	human Plasmin, recombinant	100 ug
P0U	Urokinase	1 mg
P015	Streptokinase (bacterial plasminogen activator)	1 mg
P016	Tissue Plasminogen Activator	100 ug
P111	PEPperCHIP Pan-Transglutaminase Microarray	1 Chip
P112	PEPperCHIP Custom Transglutaminase Microarray	1 Chip
P113	PEPperCHIP Transglutaminase Microarray Service	1 Sample
P114	PepSlide Analyzer	3-Month/1-Year/Perpetual License
P115	PEPperCHIP Incubation Tray 3/1	1 Tray
P116	PEPperCHIP Staining Kit	1 Kit
P117	PEPperCHIP Transglutaminase 2 Microarray	1 Chip
P118	PEPperCHIP Incubation Tray 3/5	1 Tray
R001	N-(Tetrametylrhodaminyl)cadaverine	10 mg
R002	TAMRA-DON	5 mg 10 mg
T001	Microbial (bacterial) transglutaminase	25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U
T002	Human tissue transglutaminase (TG2)	250 ug 1mg
T004	N-(p-Tosyl)-Gly-Pro-Lys-pNA	25 mg
T006	Guinea pig liver transglutaminase	10U
T009	Human keratinocyte transglutaminase (TG1)	150 ug
T011	Human transglutaminase 7	250 ug
T013	Human epidermal transglutaminase, Dispose activated	200 ug
T016	Microbial (bacterial) Pro-transglutaminase	250 ug
T018	Inactive human tissue transglutaminase	250 ug 1 mg
T021	Human neuronal transglutaminase (TG6)	250 ug
T022	Human tissue transglutaminase (TG2)	250 ug 1 mg
T024	Human epidermal transglutaminase (TG3)	200 ug
T027	Human blood coagulation Factor Xlll-A z recombinant	200 ug
T034	Human tissue transglutaminase (TG2)	100 ug
T035	Human keratinocyte transglutaminase (TGI)	150 ug
T036	Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine	1 Kit
T038	Rat tissue transglutaminase	250 ug 1 mg
T039	Guinea pig liver transglutaminase, recombinant	10U
T040	Mouse tissue transglutaminase	250 ug 1 mg
T042	Human prostate Transglutaminase (TG4)	100 ug
T050	Human blood coagulation Factor XIII B subunit	200 ug
T051	Open tTG™	250 ug
T055	Tissue Transglutaminase Microassay Kit, colorimetric	1 Kit
T056	Human alpha thrombin, highly active	200 U
T057	Inhibited human epidermal transglutaminase	250 ug
T061	Mouse blood coagulation Factor Xlll-A2	200 ug
T062	Dog blood coagulation Factor Xlll-A2	200 ug
T063	Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant	200 ug
T064	Inhibited human neuronal transglutaminase	250 ug
T065	Rat blood coagulation Factor Xlll-A2	200 ug
T066	Pig blood coagulation Factor Xlll-A2	200 ug
T067	Human tissue transglutaminase (TG2), endotoxin free	250 ug 1 mg
T070	Human Factor Xllla, Thrombin activated	200 ug
T072	Dog tissue transglutaminase	250 ug 1 mg
T086	Human Transglutaminase 5	100 ug
T087	Tridegin	200 ug
T092	Human blood coagulation Factor Xlll-A2	100 ug
T101	1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride	10 mg
T102	Mouse Open TG2	250 ug 1 mg
T106	Biotinylated human tissue transglutaminase (TG2)	100 ug 250 ug
T108	Cynomolgus tissue transglutaminase	250 ug
T109	Cynomolgus open TG2	100 ug
T1 10	Recombinant TG2 [E.coli]	500 ug
T1 14	Blood Coagulation Factor Xlll-Microassay Kit, colorimetric	1 Kit
T117	Biotinylated inactive hTG2 (Cys277Ser)	250 ug 1 mg
T122	Recombinant TG2 (insect cells)	500 ug
T123	Biotinylated human tissue transglutaminase (TG2)	50 ug
T124	Recombinant TG3 (insect cells)	400 ug
T127	Biotinylated human blood coagulation Factor XIII	50 ug
T134	Open tTG™	100 ug
T139	Rabbit tissue transglutaminase	250 ug 1mg
T140	Biotinylated human epidermal transglutaminase	100 ug
T141	Biotinylated human neuronal transglutaminase	100 ug
T142	Biotinylated mouse blood coagulation Factor Xlll-A2	50 ug
T146	Mouse neuronal transglutaminase	250 ug
T148	Biotinylated human Open tTG™	50 ug 1 mg
T149	Oxidized inactive human tissue transglutaminase	250 ug 1 mg
T150	Biotinylated mouse open TG2	50 ug
T151	Biotinylated oxidized inactive human tissue transglutaminase	250 ug 1 mg
T152	Rabbit blood coagulation Factor Xlll-A2	200 ug
T153	Microbial (bacterial) transglutaminase, edotoxin free	25 U;10x 25 U;20x 25 U
T156	Biotinylated mouse tissue transglutaminase	250 ug; 1 mg
T159	Pig tissue transglutaminase	250 ug; 1 mg
T160	Biotinylated cynomolgus tissue transglutaminase	50 ug
T161	Cynomolgus blood coagulation Factor Xlll-A2	200 ug
T167	Short human tissue transglutaminase, aa 1-475	250 ug
T168	Human tissue transglutaminase, C23OA mutant	250 ug;1 mg
T169	Human tissue transglutaminase, R580A mutant	250 ug;1 mg
T173	Human tissue transglutaminase, R116C mutant	1 mg
T178	Microbial transglutaminase with C-terminal His6-tag	25 U;10 x 25 U;20 x 25 U
T184	Cat tissue transglutaminase	200 ug
T187	Factor XIII activation peptide, recombinant	500 ug
T197	Coagulation factor XIII, recombinant human Factor Xlll-A2	100E;250E
T222	Human alpha Thrombin, recombinant	100 NIH Units
Z004	Z-Gln-GIn-Pro-Leu-OH	25 mg
Z006	Z-DON-Val-Pro-Leu-OMe,"Z-DON"	10 mg
Z009	ZediXclusive Microbial Transglutaminase Assay Kit	1 Kit
Z010	ZediXclusive Tissue Transglutaminase Assay Kit	1 Kit
Z011	Z-(D)-DON-Val-Pro-Leu-OMe	10 mg
Z013	Z-MA-QPL-OMe	10 mg
Z015	Keillor inhibitor AA9	10 mg
Z016	Keillor inhibitor NC9	10 mg
Z017	Keillor inhibitor VA4	10 mg

< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Zedira"> Zedira

...

阅读详情

Bioassay Systems.jpg

艾美捷科技代理Bioassay Systems全系列ELISA试剂盒产品。

美国博世生物技术有限公司(BioAssay Systems) 以研发、生产和销售高品质的生物检测制剂为主；公司产品种类齐全，主要用于科学研究和生物医药开发；客户涵盖药物研发公司、生物技术公司、各大专院校、医院、环境和食品卫生部门等。

涵盖领域包括

» Blood & Urine Chemistry

» Metabolism

» Enzyme Activity

» Anions & Cations

» Oxidative Stress

» Signal Transduction

» HTS Reagents

» Other Reagents

Bioassay System的主要产品包括：

血液尿液化学

酶活性测定

能量代谢

氧化应激

高通量HTS试剂

阴阳离子检测

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Bioassay Systems全系列ELISA试剂盒"> 艾美捷科技代理Bioassay Systems全系列ELISA试剂盒

...

阅读详情

Foxx Life Sciences公司位于美国新罕布什尔州Salem，是一家专门从事实验室耗材研发、生产、销售的公司，旗下产品主要包括1）一次性耗材；2）过滤用品；3）液体管理用品；4）实验室生物安全用品；5）玻璃器皿等。

Foxx Life Sciences provides engineering services, OEM and Foxx labeled proprietary products to leading research and distribution companies for a wide variety of applications. Through strategic planning and acquisition, commitment, and hard work, Foxx has developed an unparalleled reputation for technical expertise, quality and value. Our focus on next generation patented filtration, fluid management, and solvent waste products has accelerated our customers’ critical product-to-market timing objectives – a vital advantage in today’s competitive market.

产品主要包括：

（1）SINGLE-USE BIOPROCESS

Custom Assembly

EZBio® Anchors

EZBio® Bottles

EZBio® Bottle Assy.

EZBio® Cap Assy.

EZBio® Custom Bags

EZBio® Vent Filters

EZTop® Fluid Transfer

Filling & Venting

Sanitary Clamps

Silicone Tubing

True Union Clamps

（2）FILTRATION

Autofil® Bottle-Top

Autofil® Centrifuge

Autofil® Hardware

EZFlow® Cell Strainers

EZFlow® Glass Filtration

EZFlow® Membrane Discs

EZFlow® Syringe Filters

Vent Filters

（3）FLUID MANAGEMENT

Caps & Adapters

Carboys

Centrifuge Bottles

Erlenmeyer Flasks

HD Vacuum Bottles

Mixing

SECUREgrasp® Media Bottles

Storage Bottles

Secondary Containers

Teras Turbine Mixer

Tight-Head Containers

Vactrap™

VersaBarb & Spigots

Brewtainers

（4）LABORATORY SAFETY

HPLC Solvent Waste

Safety Cans

Safety Funnels

Accessories

Tubing Adapters

Vactrap™

（5）BOROSIL GLASSWARE

PUREGRIP® Bottles

PUREGRIP® Carboys

PUREGRIP® Flasks

Beakers

Bottles

Burettes

Condensers

Culture Tubes

Cylinders

Dessicators

Filtration Assembly

Funnels

Glass Flasks

Glass Stirrers

Pipettes

Test Tubes

Volumetric Flask

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Foxx Life Sciences"> Foxx Life Sciences

...

阅读详情

艾美捷科技代理Abliance品牌全系列产品

Abliance是一家法国的抗体制造商和服务提供商，由专家组成的团队，在细胞培养、蛋白质工程和质量控制方面拥有深厚专业知识，专注为体外诊断（IVD）及科研领域提供高合规性抗体解决方案，满足研究和诊断工业市场的抗体需求。

▍Abliance公司产品提供丰富可选择的抗体库

多物种来源	多特异性靶点	多样标记方式	多级适用品质
anti-human Ig	anti-IgG, IgM, IgA	fluorescent	globulins
anti-mouse and rabbit Ig	anti-IgGAM	enzymatic	affinity purified antibodies
anti-goat, bovine, dog Ig ...	anti-Fc and Fab fragments	biotin	Fab and F(ab')2 fragments

● Abliance的二抗产品为多克隆抗体，通过使用人或动物免疫球蛋白对实验动物（兔、山羊或绵羊）进行高效免疫后获得。收集的免疫血清除含有目标特异性抗体外，还包含非特异性抗体及血清杂蛋白。

● Globulins：经过系列非特异性纯化步骤（脱脂处理→硫酸铵沉淀→透析）后获得球蛋白组分，此中间产物适用于免疫沉淀技术。

● Affinity purified antibodies：随后通过亲和层析对抗体进行纯化，从而确保高特异性。此外，抗鼠/兔IgG（H+L）二抗需在装有人源IgA/IgG/IgM的凝胶层析柱上进行系统化吸附处理，确保其与人源IgA/IgG/IgM无交叉反应。

● Fragments：Abliance提供经酶切获得的F(ab')₂和Fab片段，适用于免疫组化/细胞学检测及流式细胞术等场景。相较于含Fc区的完整抗体，这些片段能显著降低非特异性结合。其更小的分子量可增强细胞和组织渗透性。

● Labeled antibodies：Abliance供应多样标记物复合体：球蛋白组分、纯化抗体及Fab/F(ab')₂片段，可与荧光染料（异硫氰酸荧光素）、酶类（过氧化物酶、碱性磷酸酶、β-半乳糖苷酶、葡萄糖氧化酶）及生物素进行偶联。

▍Abliance部分产品列表

货号	品名	规格	Host	Antigen
BI 1014	Anti-Human IgGAM Globulin	4mg/2ml	Goat	Human IgGAM
BI 1015	Anti-Human IgG (H+L) Globulin	4mg/2ml	Goat	Human IgG (H+L)
BI 1016	Anti-Human IgA (alpha) Globulin	4mg/2ml	Goat	Human IgA (alpha)
BI 1018	Anti-Human IgG (gamma) Globulin	4mg/2ml	Goat	Human IgG (gamma)
BI 1019	Anti-Human IgM (µ) Globulin	4mg/2ml	Goat	Human IgM (µ)
BI 1025	Anti-Human albumin Globulin	4mg/2ml	Goat	Human albumin
BI 3014	Anti-Human IgGAM Fab	2mg/1ml	Goat	Human IgGAM
BI 3015	Anti-Human IgG (H+L) Fab	2mg/1ml	Goat	Human IgG (H+L)
BI 3016	Anti-Human IgA (alpha) Fab	2mg/1ml	Goat	Human IgA (alpha)
BI 3018	Anti-Human IgG (gamma) Fab	2mg/1ml	Goat	Human IgG (gamma)
BI 3019	Anti-Human IgM (µ) Fab Goat	2mg/1ml	Goat	Human IgM (µ)
BI 3025	Anti-Human albumin Fab	2mg/1ml	Goat	Human albumin
BI 4015	Anti-Human IgG (H+L) F(ab')2	2mg/1ml	Goat	Human IgG (H+L)
BI 4016	Anti-Human IgA (alpha) F(ab')2	2mg/1ml	Goat	Human IgA (alpha)
BI 4018	Anti-Human IgG (gamma) F(ab')2	2mg/1ml	Goat	Human IgG (gamma)
BI 4019	Anti-Human IgM (µ) F(ab')2	2mg/1ml	Goat	Human IgM (µ)
BI 4025	Anti-Human albumin F(ab')2	2mg/1ml	Goat	Human albumin
BI 3414	Anti-Human IgGAM Fab HRP	1ml	Goat	Human IgGAM
BI 3415	Anti-Human IgG (H+L) Fab HRP	1ml	Goat	Human IgG (H+L)
BI 3416	Anti-Human IgA (alpha) Fab HRP	1ml	Goat	Human IgA (alpha)
BI 3418	Anti-Human IgG (gamma) Fab HRP	1ml	Goat	Human IgG (gamma)
BI 3419	Anti-Human IgM (µ) Fab HRP	1ml	Goat	Human IgM (µ)
BI 3425	Anti-Human albumin Fab HRP	1ml	Goat	Human albumin
BI 4414	Anti-Human IgGAM F(ab')2 HRP	1ml	Goat	Human IgGAM
BI 4415	Anti-Human IgG (H+L) F(ab')2 HRP	1ml	Goat	Human IgG (H+L)
BI 4419	Anti-Human IgM (µ) F(ab')2 HRP	1ml	Goat	Human IgM (µ)
BI 4425	Anti-Human albumin F(ab')2 HRP	1ml	Goat	Human albumin

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Abliance品牌全系列产品"> 艾美捷科技代理Abliance品牌全系列产品

...

阅读详情

艾乐美生物科技有限公司（AllerMAbs Co., Ltd.）成立于2015年，是台湾一家专注于生产高亲和力、高纯度并具有过敏原特异性的嵌合人类IgE单克隆抗体的生物公司。公司创办人团队在科研过程中发现市面上缺乏多样的IgE单克隆抗体，特別是具有过敏原特异性的人IgE 单抗。如果能制备出这种抗体，将有助于IgE 相关领域的研究工作。因此，AllerMAbs公司团队开始思考与研究利用基因克隆动物来制造人类 IgE 抗体的可行性，经过数年的努力于 2014年开发出人类IgE 抗体基因嵌入小鼠，通过杂交瘤技术 (Hybridoma technology)，成功地研制出分泌嵌合人类IgE 单抗的 IgE 杂交瘤与纯化 IgE 抗体。经测试，此种嵌合人类IgE 单抗的物化性质与对免疫细胞的活性，皆与人类IgE 抗体一致，研究成果于2015 年发表在国际学术期刊上。

AllerMAbs的产品解决了目前人类IgE抗体不易制备的问题，让嵌合人类IgE抗体可以成为人类IgE抗体的替代品，并提供一个更稳定、更符合血清IgE检测系统的校正品，让临床血清IgE的检测结果更加准确与可靠。

其利用动物基因转殖技术，将组成人类IgE抗体分子的ε重链(Heavy chain)和κ轻链(Light chain)的编码基因(Encoding genes)，分別嵌入(Knock-in)小鼠胚胎干细胞(Embryonic stem cells, ES cells)的γ1重链和κ轻链基因的位置，接着把胚胎干细胞分別植入孕母鼠体内，并将其带有嵌入基因之成鼠交互配种，最后得到带有人类IgE抗体重链和轻链基因的基因嵌入小鼠(HεκKI mice)，且体内能制造完整的嵌合人类IgE抗体分子。

技术优势

容易制备IgE杂交瘤与IgE单抗

过敏原特异性

良好的亲和力与专一性

高纯度与高稳定性

可结合至嗜碱性粒细胞上的IgE受体与刺激細胞

可大量生产与高浓度制备

非人类血液来源(相较于血清IgE抗体)

适合用作检测用的校正品

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="AllerMAbs"> AllerMAbs

...

阅读详情

Novamatrix隶属于FMC旗下健康与营养业务部门，主要生产高纯度生物相容性和可吸收性生物多聚体，应用于制药、生物技术、生物医疗等领域，例如给药、组织工程、细胞内吞等方面。

Novamatrix的主要产品包括：

Ultrapure alginate

Peptide-coupled alginate

Hyaluronan

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Novamatrix"> Novamatrix

...

阅读详情

艾美捷科技特约代理BioVendor产品。

BioVendor专注于为分子和细胞学实验室提供体外研究产品，主要产品有重组蛋白、抗体和ELISA试剂盒。目前公司致力于有关激素和细胞活素利用方面的研究，产品相关方向：能量代谢和体重调节；骨代谢；心血管疾病和肾病；感染和发炎；铁代谢研究；肌肉生长控制；神经组织损坏标记；肿瘤学；胰腺调节分子；分泌型磷脂酶A2等。

BioVendor group is an internationally operating group of companies with its own research & development and manufacturing capability. In 2012, BioVendor – Laboratorní medicína joined forces with Test Line Clinical Diagnostics followed by BioVendor Instruments, Immunolab, ViennaLab Diagnostics and Genetrac by the end of 2016. We have established a synergistic and quality-based portfolio which allows us to serve professionals from the fields of biomedical research, clinical diagnostics, veterinary diagnostics and food analysis.

BioVendor公司的主要产品包括：

Immunoassays

Proteins

Antibodies

miRNA

Planar Arrays

Immunohistochemistry

Endotoxin Detection Products

Cell-Based Assays

Extracellular Matrix Assays

Advanced Microscopes

Liquid Biopsy

Real-time PCR

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioVendor"> BioVendor

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

英国Immuquest公司主要提供细胞周期、核相关、干细胞分化以及肿瘤标志物等相关抗体。

Founded in 2002, ImmuQuest offers a range of UNIQUE and NOVEL antibodies manufactured to the highest possible quality, at the forefront of scientific research.

Everything we do is developed with the needs of the researcher in mind. Wherever possible, our antibodies are tested across applications such as WB, ELISA, IHC (frozen and paraffin sections) and ICC/IF and published in our Datasheets. Many can be supplied in BESPOKE formats. The majority of Immuquest's antibodies are manufactured under our own strict control. That means that you will always know what you are ordering is of the highest possible quality.

ImmuQuest的主要产品包括：

Stem Cells

Transcription

Cardiovascular

Ageing

Cancer

Cell Biology

Cell Division

Cell Architecture

Tags & Cell Markers

Human Disease

Immunology

Inherited Diseases

Microbiology

Nuclear Signalling

Neuroscience

Signal Transduction

Sub Cellular markers

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ImmuQuest"> ImmuQuest

...

阅读详情

323 324 325 326 327 328 329 330 331 332

城市分站

友情链接 invivoCrown IV0121替换BioXCell BE0001-1 invivoCrown IV0107替换BioXCell BE0273 invivoCrown IV0110替换BioXCell BE0058 invivoCrown IV0114替换BioXCell BE0213 invivoCrown IV0100替换BioXCell BE0146 艾美捷科技代理Spectrum Chemical品牌艾美捷科技代理Exocell品牌艾美捷科技代理Industria Chimica Emiliana (ICE) 品牌艾美捷科技代理Sorachim品牌艾美捷科技代理Sequins全系列产品

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18372041646

传真：17754422825

邮箱：sales@amyjet.com

0.3318